These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23776841)

  • 21. Evaluation of Prosopis africana Seed Gum as an Extended Release Polymer for Tablet Formulation.
    Nadaf S; Nnamani P; Jadhav N
    AAPS PharmSciTech; 2015 Jun; 16(3):716-29. PubMed ID: 25523143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A New Extrudable Form of Hypromellose: AFFINISOLâ„¢ HPMC HME.
    Huang S; O'Donnell KP; Keen JM; Rickard MA; McGinity JW; Williams RO
    AAPS PharmSciTech; 2016 Feb; 17(1):106-19. PubMed ID: 26335416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formulation and evaluation of effervescent floating tablets of tizanidine hydrochloride.
    Someshwar K; Chithaluru K; Ramarao T; Kumar KK
    Acta Pharm; 2011 Jun; 61(2):217-26. PubMed ID: 21684848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formulation and evaluation of a sustained-release tablets of metformin hydrochloride using hydrophilic synthetic and hydrophobic natural polymers.
    Wadher KJ; Kakde RB; Umekar MJ
    Indian J Pharm Sci; 2011 Mar; 73(2):208-15. PubMed ID: 22303065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controlled-release carbamazepine matrix granules and tablets comprising lipophilic and hydrophilic components.
    Barakat NS; Elbagory IM; Almurshedi AS
    Drug Deliv; 2009 Jan; 16(1):57-65. PubMed ID: 19555310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. STUDYING THE IMPACT OF FORMULATION AND PROCESSING PARAMETERS ON THE RELEASE CHARACTERISTICS FROM HYDROXYPROPYL METHYLCELLULOSE MATRIX TABLETS OF DICLOFENAC.
    Elzayat EM; Abdel-Rahman AA; Ahmed SM; Alanazi FK; Habib WA; Sakr A
    Acta Pol Pharm; 2016; 73(2):439-52. PubMed ID: 27180437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of pH and ionic strength of dissolution media on in-vitro release of two model drugs of different solubilities from HPMC matrices.
    Asare-Addo K; Conway BR; Larhrib H; Levina M; Rajabi-Siahboomi AR; Tetteh J; Boateng J; Nokhodchi A
    Colloids Surf B Biointerfaces; 2013 Nov; 111():384-91. PubMed ID: 23850747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formulation Development and Optimization of Matrix Tablet of Tramadol Hydrochloride.
    Deb P; Singha J; Chanda I; Chakraborty P
    Recent Pat Drug Deliv Formul; 2017; 11(1):19-27. PubMed ID: 27712568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug release-modulating mechanism of hydrophilic hydroxypropylmethylcellulose matrix tablets: distribution of atoms and carrier and texture analysis.
    Park JB; Lim J; Kang CY; Lee BJ
    Curr Drug Deliv; 2013 Dec; 10(6):732-41. PubMed ID: 23855499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Guar gum, xanthan gum, and HPMC can define release mechanisms and sustain release of propranolol hydrochloride.
    Mughal MA; Iqbal Z; Neau SH
    AAPS PharmSciTech; 2011 Mar; 12(1):77-87. PubMed ID: 21174179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Response surface optimization of sustained release metformin-hydrochloride matrix tablets: influence of some hydrophillic polymers on the release.
    Roy A; Roy K; Roy S; Deb J; Ghosh A; Ali KA
    ISRN Pharm; 2012; 2012():364261. PubMed ID: 22988527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative release profile of sustained release matrix tablets of verapamil HCl.
    Mathur V; Nagpal K; Singh SK; Mishra DN
    Int J Pharm Investig; 2013 Jan; 3(1):60-5. PubMed ID: 23799207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Irvingia gabonensis (O'Rorke) Bail polymer matrix system for controlled drug delivery.
    Patani BO; Akin-Ajani OD; Kumaran A; Odeku OA
    Polim Med; 2022; 52(2):67-76. PubMed ID: 36268745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and evaluation of Ketoprofen sustained release matrix tablet using
    Kaleemullah M; Jiyauddin K; Thiban E; Rasha S; Al-Dhalli S; Budiasih S; Gamal OE; Fadli A; Eddy Y
    Saudi Pharm J; 2017 Jul; 25(5):770-779. PubMed ID: 28725150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and in vitro analysis of floating matrix tablets of metronidazole using Brachystegia eurycoma gum.
    Ovenseri AC; Clifford O; Uwumagbe UM
    Pak J Pharm Sci; 2018 Jul; 31(4):1243-1249. PubMed ID: 30033407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastroretentive drug delivery system of metoclopramide hydrochloride: formulation and in vitro evaluation.
    Singh S; Singh J; Muthu MS; Balasubramaniam J; Mishra B
    Curr Drug Deliv; 2007 Oct; 4(4):269-75. PubMed ID: 17979646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formulation and Evaluation of Multilayered Tablets of Pioglitazone Hydrochloride and Metformin Hydrochloride.
    Chowdary YA; Raparla R; Madhuri M
    J Pharm (Cairo); 2014; 2014():848243. PubMed ID: 26556204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formulation and evaluation of cephalexin extended release matrix tablets using 3 factorial design.
    Jishnu V; Prabhakaran R; Gilhotra R
    J Young Pharm; 2011 Oct; 3(4):259-66. PubMed ID: 22224031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controlled-release carbamazepine granules and tablets comprising lipophilic and hydrophilic matrix components.
    Barakat NS; Elbagory IM; Almurshedi AS
    AAPS PharmSciTech; 2008; 9(4):1054-62. PubMed ID: 18843537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bilayer Tablet Formulation of Metformin HCl and Acarbose: A Novel Approach To Control Diabetes.
    Tiwari R; Gupta A; Joshi M; Tiwari G
    PDA J Pharm Sci Technol; 2014; 68(2):138-52. PubMed ID: 24668601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.